Auditory Agnosia in Autoimmune Encephalitis

Autoimmune encephalitis (AIE) is an increasingly recognized cause of acute encephalopathy, commonly accompanied by seizures and other neurologic symptoms and signs. Despite a predilection for mesial temporal structures and occasionally the thalami, hearing loss and other auditory symptoms are not commonly reported.Herein, we report a case of possible Contactin-associated protein-like 2 (CASPR2) related AIE resulting in chronic auditory agnosia. A 21-year-old woman presented to the hospital with 3–4 days of confusion and fever followed by new onset generalized tonic-clonic seizures. Due to refractory seizure activity, she was intubated in the emergency room with subsequent transfer to the critical care unit. Cerebrospinal fluid (CSF) studies showed a lymphocytic pleocytosis with a white cell count of 146 × 106 (reference range 0–5 × 106) and elevated protein at 1.32 g/L (reference range 0.15–0.45 g/L) with negative infectious work-up (see Table 1). Serum and CSF testing for encephalitis and paraneoplastic antibodies showed positive CASPR2 antibodies in the serum only (cell-based assay without confirmatory tissue-based assay, 1:100 dilution, Mitogen Diagnostics). Continuous EEG showed focal electrographic seizures and epileptiform discharges arising from bilateral occipital regions (Figure 1a). Initial MRI demonstrated increased T2/ FLAIR signal in the medial thalami bilaterally without enhancement (Figure 1b). Her extended work-up was otherwise unremarkable (see Table 1). Based on the clinical phenotype, CSF findings and lack of other etiology, a diagnosis of possible AIE was made. Initial treatment consisted of intravenous immunoglobulin (2 g/kg over 5 days) and intravenous methylprednisolone (1 g daily for 5 days). However, due to persistent refractory seizures with weaning of sedation and ongoing encephalopathy, her treatment was escalated to plasmapheresis (five exchanges over 10 days) followed by rituximab (1000mg IV for two doses, 2 weeks apart). She was extubated and transitioned to oral anti-epileptics 4 days after her first dose of rituximab and 1 day after completion of apheresis. She had no further witnessed seizures and demonstrated slow improvement in cognition over the remainder of her hospitalization. A PET scan of the brain done 2 months after admission demonstrated marked hypometabolism of the anterior left thalamus and moderate hypometabolism of both caudate nuclei. There was patchy mild hypometabolism in the temporal lobes (predominantly hippocampal regions and mesial temporal Table 1: Additional testing done at initial work-up

Autoimmune encephalitis (AIE) is an increasingly recognized cause of acute encephalopathy, commonly accompanied by seizures and other neurologic symptoms and signs. Despite a predilection for mesial temporal structures and occasionally the thalami, hearing loss and other auditory symptoms are not commonly reported. Herein, we report a case of possible Contactin-associated protein-like 2 (CASPR2) related AIE resulting in chronic auditory agnosia.
A 21-year-old woman presented to the hospital with 3-4 days of confusion and fever followed by new onset generalized tonic-clonic seizures. Due to refractory seizure activity, she was intubated in the emergency room with subsequent transfer to the critical care unit. Cerebrospinal fluid (CSF) studies showed a lymphocytic pleocytosis with a white cell count of 146 × 10 6 (reference range 0-5 × 10 6 ) and elevated protein at 1.32 g/L (reference range 0.15-0.45 g/L) with negative infectious work-up (see Table 1). Serum and CSF testing for encephalitis and paraneoplastic antibodies showed positive CASPR2 antibodies in the serum only (cell-based assay without confirmatory tissue-based assay, 1:100 dilution, Mitogen Diagnostics). Continuous EEG showed focal electrographic seizures and epileptiform discharges arising from bilateral occipital regions (Figure 1a). Initial MRI demonstrated increased T2/ FLAIR signal in the medial thalami bilaterally without enhancement ( Figure 1b). Her extended work-up was otherwise unremarkable (see Table 1).
Based on the clinical phenotype, CSF findings and lack of other etiology, a diagnosis of possible AIE was made. Initial treatment consisted of intravenous immunoglobulin (2 g/kg over 5 days) and intravenous methylprednisolone (1 g daily for 5 days). However, due to persistent refractory seizures with weaning of sedation and ongoing encephalopathy, her treatment was escalated to plasmapheresis (five exchanges over 10 days) followed by rituximab (1000 mg IV for two doses, 2 weeks apart). She was extubated and transitioned to oral anti-epileptics 4 days after her first dose of rituximab and 1 day after completion of apheresis. She had no further witnessed seizures and demonstrated slow improvement in cognition over the remainder of her hospitalization. A PET scan of the brain done 2 months after admission demonstrated marked hypometabolism of the anterior left thalamus and moderate hypometabolism of both caudate nuclei. There was patchy mild hypometabolism in the temporal lobes (predominantly hippocampal regions and mesial temporal  structures), the left orbital frontal region, and the lateral associative cortex of the occipital lobes. No areas of hypermetabolism were seen. Neurologic exam 6 months after initial presentation demonstrated absent comprehension of speech, impaired repetition and naming difficulty with low-frequency objects but fluent speech. Reading and writing abilities remained intact. She was dependent on voice to text transcription software for all communication. She was inconsistent in her ability to identify environmental sounds; for example, she correctly identified the sound of a car and a knock on the door but could not identify a bird singing or a car horn. Interestingly she did report hearing the sounds and could mimic them. She reported no longer enjoying music as she could not discern any melody. The remainder of her neurologic exam was grossly unremarkable, and pure tone audiometry testing was normal. A diagnosis of auditory agnosia was made based on her inability to understand verbal and environmental sounds with otherwise preserved language and hearing. Her follow-up electrocencephalograms (EEG) continue to demonstrate bilateral temporo-occipital epileptiform discharges without clear clinical correlate or electrographic seizures. The MRI changes improved over the next 1.5 years with complete normalization on followup imaging at 2.5 years from onset.
Ongoing follow-up 3 years later has revealed persistence of the auditory agnosia with significant functional impairment in daily communication. The patient has been unable to return to school or find employment because of her symptoms.
Auditory agnosia is defined as an impairment in perceiving or understanding sounds despite intact hearing and otherwise retained language function including reading, writing, and speech. 1 Subtypes include verbal auditory agnosia (inability to understand spoken words), non-verbal agnosia (inability to understand environmental sounds), and amusia (inability to discriminate pitch or recognize melodies). 1-3 Auditory agnosia may result from bilateral lesions to any structure along the auditory pathway, including the temporal lobes or the medial geniculate bodies of the thalamus. 4 Unilateral lesions, typically affecting the auditory cortex, have also been reported as well as bilateral lesions of the pons and midbrain. 2,4 Vascular etiologies remain the most common cause of auditory agnosia, often located in the bilateral temporal lobes. 2,4 Other notable causes include herpes simplex encephalitis, 1 Landau-Kleffner syndrome, 5 and dementia. 1,6 Amusia can occur as an isolated finding in otherwise healthy individuals. 3 To our knowledge, AIE has not previously been reported as an etiology of auditory agnosia.
Isolated bilateral medial thalamic lesions are reported in patients with status and/or focal seizures and typically, but not always, resolve rapidly with control of the underlying seizure disorder. 7 Pulvinar involvement, however, is not reported as an isolated finding in CASPR-related encephalitis. Accordingly, the etiology of the MR changes in our patient remain unclear and may be sequelae of seizure activity rather than direct effects of her presumed AIEs. Additionally the significance of her isolated CASPR2 antibody positivity is unknown given her clinical and imaging phenotype was atypical for CASPR2 encephalitis and no tissue-based corroborative assay was done. 8 Nonetheless, we suspect in our case that either the bilateral thalamic lesions including the medial geniculate bodies or mesial temporal lobe involvement demonstrated on the PET scan (or both) were responsible for disruption to the auditory pathways leading to auditory agnosia. The auditory agnosia has persisted despite marked improvement in cognition and absence of ongoing seizures. It continues to cause significant functional impairment. Optimal therapy for patients with auditory agnosia remains unclear but speech therapy targeted at using alternate forms of communication including lip reading is recommended. 4 This case highlights that while many patients recover very well long term with AIE, even with early aggressive therapy, persistent focal deficits do occur and can result in significant long-term disability.
Disclosures. CH, PF, and KW report no disclosures.
Statement of Authorship. KW drafted the manuscript. CH and PF acquired the data and revised the manuscript.